NCT06719635

Brief Summary

Chronic pelvic pain remains a challenging disorder to treat because of the complexities of pain sensation and unclear etiology. Standard medical and surgical treatments seldom prove effective at improving quality of life and pain intensity among affected women.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

December 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 6, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

December 7, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 6, 2026

Status Verified

November 1, 2025

Enrollment Period

1.8 years

First QC Date

December 2, 2024

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual analogue pain score

    The percentage of patients who achieved \> 50% decline in their Visual analogue pain score "from the baseline value" before intervention at the end of the first month.

    At the end of the first month after the procedure.

Secondary Outcomes (2)

  • Daily analgesic requirements

    At the end of the first 2 weeks, 1st month, 2nd month, 3rd month, and 6th month after the procedure.

  • Associated adverse events

    At the end of the first month after the procedure.

Study Arms (2)

Laparoscopic Presacral Neurectomy

ACTIVE COMPARATOR

The patients will undergo Laparoscopic Presacral Neurectomy under general anesthesia.

Procedure: Laparoscopic Presacral Neurectomy

Fluoroscopically guided Superior Hypogastric Neurolysis

ACTIVE COMPARATOR

The patients will receive fluoroscopically guided Superior Hypogastric Plexus Neurolysis with Radiofrequency of the Sacral Roots 2,3,4.

Procedure: Fluoroscopically guided Superior Hypogastric Plexus Neurolysis

Interventions

Laparoscopy will be performed under general anesthesia. Then, nerve plexuses will be identified and freed from their underlying tissue, which contains the left common iliac and middle sacral veins. This will be followed by cauterization and cutting of the nerve plexuses.

Laparoscopic Presacral Neurectomy

The patients will receive fluoroscopically guided Superior Hypogastric Plexus Neurolysis using 3 mL of 75% ethanol and Radiofrequency of the Sacral nerve Roots 2-4.

Fluoroscopically guided Superior Hypogastric Neurolysis

Eligibility Criteria

Age21 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient acceptance.
  • Body mass index \< 35 kg/m2.
  • Adult patients with chronic pelvic and perineal pain due to pelvic cancer.
  • Visual Analog Scale pain score ≥ 5 on a 0-10 scale despite treatment with a standard analgesic.

You may not qualify if:

  • Uncooperative patient.
  • Patients with coagulopathy, infection at the site of injection, severe cardiac compromise, or intolerance to sympathetic block.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig university hospital

Zagazig, Al-Sharkia, 44519, Egypt

Location

Related Publications (4)

  • de Leon-Casasola OA, Kent E, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain. 1993 Aug;54(2):145-151. doi: 10.1016/0304-3959(93)90202-Z.

    PMID: 8233527BACKGROUND
  • Ghai V, Subramanian V, Jan H, Pergialiotis V, Thakar R, Doumouchtsis SK; CHORUS: An International Collaboration for Harmonising Outcomes, Research, Standards in Urogynaecology, Women's Health. A systematic review on reported outcomes and outcome measures in female idiopathic chronic pelvic pain for the development of a core outcome set. BJOG. 2021 Mar;128(4):628-634. doi: 10.1111/1471-0528.16412. Epub 2020 Sep 1.

    PMID: 32654406BACKGROUND
  • Hetta DF, Mohamed AA, Abdel Eman RM, Abd El Aal FA, Helal ME. Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Pain Physician. 2020 Mar;23(2):149-157.

    PMID: 32214294BACKGROUND
  • Soysal ME, Soysal S, Gurses E, Ozer S. Laparoscopic presacral neurolysis for endometriosis-related pelvic pain. Hum Reprod. 2003 Mar;18(3):588-92. doi: 10.1093/humrep/deg127.

    PMID: 12615830BACKGROUND

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Abdalla Mohamed Gouda, MD

    Department of Anesthesia, Intensive Care & Pain Management, Zagazig University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2024

First Posted

December 6, 2024

Study Start

December 7, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 6, 2026

Record last verified: 2025-11

Locations